Skip to content

China Salt Substitute and Stroke Study

A LARGE-SCALE CLUSTER RANDOMIZED TRIAL TO DETERMINE THE EFFECTS OF SODIUM REDUCTION ON STROKE: THE CHINA SALT SUBSTITUTE AND STROKE STUDY (SSaSS)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02092090
Acronym
SSaSS
Enrollment
20996
Registered
2014-03-19
Start date
2014-07-09
Completion date
2020-09-04
Last updated
2021-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

salt substitute, sodium reduction, stroke, cluster randomized trial, China

Brief summary

The study is a large scale cluster randomised trial to evaluate the effects of sodium reduction based upon the use of salt substitute on the risk of stroke defined as the occurrence of stroke and stroke deaths. The corresponding null hypothesis that will be tested is that sodium reduction will have no effect upon stroke risk. The secondary objectives are to determine effects of sodium reduction on major vascular events and total mortality.

Detailed description

Lowering sodium intake and the use of salt substitute have been proved to lower blood pressure levels. Effects on the risks of vascular outcomes have not been defined in an adequately powered randomised trial. Rural Chinese are known to consume very large quantities of sodium and to suffer from very high rates of hypertension and stroke. This study is a large scale cluster randomised trial done in rural areas of China. The study will define the effects of a salt substitute-based sodium reduction strategy on the primary outcome of stroke. Secondary endpoints will include major cardiovascular events and total mortality. The study will be conducted in 600 rural villages across five Northern Chinese provinces and Tibet. The study will recruit 35 individuals at elevated risk of stroke from each village for a total of 21,000 participants. The participating villages will be randomised into intervention and control group with 1:1 allocation. Recruitment will prioritise individuals with a history of stroke but also include older individuals with high blood pressure. Follow up is scheduled for 5 years. Individuals in intervention villages will receive repeated dietary advice and a supply of low sodium salt substitute while individuals in control villages will receive dietary advice at baseline only. Every 6 months throughout follow-up each individual will be contacted by phone call to inquire about the occurrence of stroke, hospitalisation for any cause and diagnoses of any other serious illnesses. The interview will be structured and done by individuals masked to the randomised assignment of each individual. For all deaths identified and all events that might possibly be non-fatal strokes a home visit will be made. A series of process indicators including urinary sodium, urinary potassium, blood pressure, knowledge about sodium and use of salt substitute will also be measured on a random sample of at least 20 individuals drawn from a random selection of 60 villages at baseline and every year thereafter.

Interventions

Ongoing dietary advice and a supply of a reduced-sodium added-potassium salt substitute

Sponsors

Peking University
CollaboratorOTHER
Northwestern University
CollaboratorOTHER
Imperial College London
CollaboratorOTHER
China Medical University, China
CollaboratorOTHER
Changzhi Medical College
CollaboratorOTHER
Centers for Disease Control and Prevention, China
CollaboratorOTHER_GOV
Ningxia Medical University
CollaboratorOTHER
Xi'an Jiaotong University
CollaboratorOTHER
The George Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Disease history * Prior stroke and/or * Aged 60 years or over and with uncontrolled high blood pressure (systolic blood pressure \>=140 millimeters of mercury (mmHg) at visit if on blood pressure lowering medication; systolic blood pressure\>=160 millimeters of mercury (mmHg) if not on blood pressure lowering medication) * Ownership of a phone by the participant or a household member

Exclusion criteria

* Participant or family member is using a potassium-sparing diuretic * Participant or family member is using a potassium supplement * Participant or family member has serious renal impairment * Participant or family member has other reason for concern about use of salt substitute * Participant eats most meals outside the home * Participant is not expected to live longer than 6 months from the date of assessment as estimated by the village doctor * Another family member living in the same household has already been included in the study

Design outcomes

Primary

MeasureTime frameDescription
Stroke5 yearsThe primary outcome will be stroke defined according to standard criteria on the basis of an acute disturbance of focal neurological function and resulting in death or symptoms lasting more than 24 hours. Imaging, clinical and laboratory data will be collected wherever possible.

Secondary

MeasureTime frameDescription
Total major vascular events5 yearsThe composite of stroke, acute coronary syndrome or vascular death
Total mortality5 years

Other

MeasureTime frameDescription
Blood Pressure5 years
Knowledge about sodium and salt substitute5 yearsKnowledge about sodium and salt substitute will be measured using the following questions at baseline and follow-up:. Is a high salt intake good for your health? Does how much salt you eat affect your blood pressure? Does how much salt you eat affect your risk of stroke? What is the daily recommended salt intake for adults? Do you try to reduce the amount of salt you eat? Do you eat pickled vegetables most days? Do you add salt to most meals? Do you add mono-sodium glutamate to most meals? Do you try to eat less of a food if it is very salty? Have you heard about low sodium salt? If yes,does your household use low-sodium salt?
Urinary sodium excretion5 years
Urinary Potassium5 years

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026